[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Armata Pharmaceuticals Inc (ARMP)

Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Armata Pharmaceuticals Inc 5005 MCCONNELL AVE LOS ANGELES CA 90066 USA

www.armatapharma.com Employees: 61 P: 310-665-2928

Sector:

Medical

Description:

Armata Pharmaceuticals Inc. is a biotechnology company. It is focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. The company's principal product candidate consist AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. It is also developing and advancing a pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa. Armata Pharmaceuticals Inc., formerly known as AmpliPhi Biosciences Corporation, is based in Marina del Rey, California.

Key Statistics

Overview:

Market Capitalization, $K 196,321
Enterprise Value, $K 290,691
Shares Outstanding, K 37,182
Float, K 5,763
% Float 15.50%
Short Interest, K 835
Short Float 2.25%
Days to Cover 6.42
Short Volume Ratio 0.68
% of Insider Shareholders 84.50%
% of Institutional Shareholders 3.57%

Financials:

Annual Sales, $ 4,900 K
Annual Net Income, $ -173,800 K
Last Quarter Sales, $ 2,510 K
Last Quarter Net Income, $ 74,140 K
EBIT, $ -35,290 K
EBITDA, $ -33,760 K

Growth:

1-Year Return 113.92%
3-Year Return 77.18%
5-Year Return 34.69%
5-Year Revenue Growth 497.56%
5-Year Earnings Growth -8.15%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.27 on 08/12/26
Next Earnings Date 11/11/26
Earnings Per Share ttm -1.59
EPS Growth vs. Prev Qtr 30.77%
EPS Growth vs. Prev Year 15.62%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-14 on 05/10/19

ARMP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 11.02
Price/Earnings to Growth N/A
Return-on-Equity % -12.24%
Return-on-Assets % 32.16%
Profit Margin % -3,546.94%
Debt/Equity -1.23
Price/Sales 41.78
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -6.30
Interest Coverage -9.48
60-Month Beta 1.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.